Sionna Therapeutics (SION) Change in Acquisitions & Divestments (2024 - 2026)
Sionna Therapeutics (SION) reported Change in Acquisitions & Divestments of $50.1 million for Q1 2026, up 64.49% on a YoY basis from $30.5 million in Q1 2025, and down 23.64% sequentially from $65.7 million in Q4 2025.
Sionna Therapeutics (SION) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Sionna Therapeutics (SION) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $50.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 64.49% year-over-year to $50.1 million; the trailing twelve-month figure through Mar 2026 stood at $226.3 million (up 161.81% YoY), and the FY2025 full-year result was $206.7 million, up 269.32% from the prior year.
- Change in Acquisitions & Divestments declined to $50.1 million in Q1 2026, from $65.7 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $77.3 million in Q3 2025 to a low of $22.5 million in Q4 2024.
- A 3-year average of $44.7 million and a median of $33.5 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments surged 192.45% in 2025 and soared 64.49% in 2026, its largest moves.
- Tracing SION's Change in Acquisitions & Divestments over 3 years: stood at $22.5 million in 2024, then surged by 192.45% to $65.7 million in 2025, then dropped by 23.64% to $50.1 million in 2026.
- Business Quant data shows SION's Change in Acquisitions & Divestments at $50.1 million in Q1 2026, $65.7 million in Q4 2025, and $77.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Sionna Therapeutics | 2.08 Bn | 2.08 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.15 Mn |
| Mar 31, 2026 | 50.15 Mn |
| Dec 31, 2025 | 65.67 Mn |
| Dec 31, 2025 | 65.67 Mn |
| Sep 30, 2025 | 77.33 Mn |
| Sep 30, 2025 | 77.33 Mn |
| Jun 30, 2025 | 33.17 Mn |
| Jun 30, 2025 | 33.17 Mn |
| Mar 31, 2025 | 30.49 Mn |
| Mar 31, 2025 | 30.49 Mn |
| Dec 31, 2024 | 22.46 Mn |
| Dec 31, 2024 | 22.46 Mn |
| Sep 30, 2024 | 33.50 Mn |
| Sep 30, 2024 | 33.50 Mn |